These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 32414297)

  • 1. Dose Range Finding Studies with Two
    Song C; Dufour VL; Cideciyan AV; Ye GJ; Swider M; Newmark JA; Timmers AM; Robinson PM; Knop DR; Chulay JD; Jacobson SG; Aguirre GD; Beltran WA; Shearman MS
    Hum Gene Ther; 2020 Jul; 31(13-14):743-755. PubMed ID: 32414297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity and Efficacy Evaluation of an Adeno-Associated Virus Vector Expressing Codon-Optimized
    Dufour VL; Cideciyan AV; Ye GJ; Song C; Timmers A; Habecker PL; Pan W; Weinstein NM; Swider M; Durham AC; Ying GS; Robinson PM; Jacobson SG; Knop DR; Chulay JD; Shearman MS; Aguirre GD; Beltran WA
    Hum Gene Ther; 2020 Feb; 31(3-4):253-267. PubMed ID: 31910043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of Retinal Gene Therapy for X-Linked Retinitis Pigmentosa Due to RPGR Mutations.
    Beltran WA; Cideciyan AV; Boye SE; Ye GJ; Iwabe S; Dufour VL; Marinho LF; Swider M; Kosyk MS; Sha J; Boye SL; Peterson JJ; Witherspoon CD; Alexander JJ; Ying GS; Shearman MS; Chulay JD; Hauswirth WW; Gamlin PD; Jacobson SG; Aguirre GD
    Mol Ther; 2017 Aug; 25(8):1866-1880. PubMed ID: 28566226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicology and Pharmacology of an AAV Vector Expressing Codon-Optimized RPGR in RPGR-Deficient Rd9 Mice.
    Song C; Conlon TJ; Deng WT; Coleman KE; Zhu P; Plummer C; Mandapati S; Van Hoosear M; Green KB; Sonnentag P; Sharma AK; Timmers A; Robinson PM; Knop DR; Hauswirth WW; Chulay JD; Shearman MS; Ye GJ
    Hum Gene Ther Clin Dev; 2018 Dec; 29(4):188-197. PubMed ID: 30280954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase 1/2 AAV5-hRKp.RPGR (Botaretigene Sparoparvovec) Gene Therapy: Safety and Efficacy in RPGR-Associated X-Linked Retinitis Pigmentosa.
    Michaelides M; Besirli CG; Yang Y; DE Guimaraes TAC; Wong SC; Huckfeldt RM; Comander JI; Sahel JA; Shah SM; Tee JJL; Kumaran N; Georgiadis A; Minnick P; Zeldin R; Naylor S; Xu J; Clark M; Anglade E; Wong P; Fleck PR; Fung A; Peluso C; Kalitzeos A; Georgiou M; Ripamonti C; Smith AJ; Ali RR; Forbes A; Bainbridge J
    Am J Ophthalmol; 2024 Nov; 267():122-134. PubMed ID: 38871269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Codon-Optimized RPGR Improves Stability and Efficacy of AAV8 Gene Therapy in Two Mouse Models of X-Linked Retinitis Pigmentosa.
    Fischer MD; McClements ME; Martinez-Fernandez de la Camara C; Bellingrath JS; Dauletbekov D; Ramsden SC; Hickey DG; Barnard AR; MacLaren RE
    Mol Ther; 2017 Aug; 25(8):1854-1865. PubMed ID: 28549772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosa.
    Beltran WA; Cideciyan AV; Lewin AS; Iwabe S; Khanna H; Sumaroka A; Chiodo VA; Fajardo DS; Román AJ; Deng WT; Swider M; Alemán TS; Boye SL; Genini S; Swaroop A; Hauswirth WW; Jacobson SG; Aguirre GD
    Proc Natl Acad Sci U S A; 2012 Feb; 109(6):2132-7. PubMed ID: 22308428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Molecularly Stable Gene Therapy Vector for the Treatment of
    Giacalone JC; Andorf JL; Zhang Q; Burnight ER; Ochoa D; Reutzel AJ; Collins MM; Sheffield VC; Mullins RF; Han IC; Stone EM; Tucker BA
    Hum Gene Ther; 2019 Aug; 30(8):967-974. PubMed ID: 31106594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AAV-RPGR Gene Therapy Rescues Opsin Mislocalisation in a Human Retinal Organoid Model of
    Sladen PE; Naeem A; Adefila-Ideozu T; Vermeule T; Busson SL; Michaelides M; Naylor S; Forbes A; Lane A; Georgiadis A
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial.
    Ghazi NG; Abboud EB; Nowilaty SR; Alkuraya H; Alhommadi A; Cai H; Hou R; Deng WT; Boye SL; Almaghamsi A; Al Saikhan F; Al-Dhibi H; Birch D; Chung C; Colak D; LaVail MM; Vollrath D; Erger K; Wang W; Conlon T; Zhang K; Hauswirth W; Alkuraya FS
    Hum Genet; 2016 Mar; 135(3):327-43. PubMed ID: 26825853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A frameshift mutation in RPGR exon ORF15 causes photoreceptor degeneration and inner retina remodeling in a model of X-linked retinitis pigmentosa.
    Beltran WA; Hammond P; Acland GM; Aguirre GD
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1669-81. PubMed ID: 16565408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene augmentation for X-linked retinitis pigmentosa caused by mutations in RPGR.
    Beltran WA; Cideciyan AV; Lewin AS; Hauswirth WW; Jacobson SG; Aguirre GD
    Cold Spring Harb Perspect Med; 2014 Oct; 5(2):a017392. PubMed ID: 25301933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin.
    Ye GJ; Budzynski E; Sonnentag P; Miller PE; Sharma AK; Ver Hoeve JN; Howard K; Knop DR; Neuringer M; McGill T; Stoddard J; Chulay JD
    Hum Gene Ther Clin Dev; 2015 Sep; 26(3):165-76. PubMed ID: 26390090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term rescue of cone photoreceptor degeneration in retinitis pigmentosa 2 (RP2)-knockout mice by gene replacement therapy.
    Mookherjee S; Hiriyanna S; Kaneshiro K; Li L; Li Y; Li W; Qian H; Li T; Khanna H; Colosi P; Swaroop A; Wu Z
    Hum Mol Genet; 2015 Nov; 24(22):6446-58. PubMed ID: 26358772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Visual Function with Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa in the Randomized XIRIUS Phase 2/3 Study.
    Lam BL; Pennesi ME; Kay CN; Panda S; Gow JA; Zhao G; MacLaren RE;
    Ophthalmology; 2024 Sep; 131(9):1083-1093. PubMed ID: 38423215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long-term efficacy study of gene replacement therapy for RPGR-associated retinal degeneration.
    Wu Z; Hiriyanna S; Qian H; Mookherjee S; Campos MM; Gao C; Fariss R; Sieving PA; Li T; Colosi P; Swaroop A
    Hum Mol Genet; 2015 Jul; 24(14):3956-70. PubMed ID: 25877300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Biodistribution Evaluation in CNGB3-Deficient Mice of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia.
    Ye GJ; Budzynski E; Sonnentag P; Nork TM; Miller PE; McPherson L; Ver Hoeve JN; Smith LM; Arndt T; Mandapati S; Robinson PM; Calcedo R; Knop DR; Hauswirth WW; Chulay JD
    Hum Gene Ther Clin Dev; 2016 Mar; 27(1):27-36. PubMed ID: 27003752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Biodistribution Evaluation of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin, in RS1-Deficient Mice.
    Ye GJ; Conlon T; Erger K; Sonnentag P; Sharma AK; Howard K; Knop DR; Chulay JD
    Hum Gene Ther Clin Dev; 2015 Sep; 26(3):177-84. PubMed ID: 26390091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Retinal Sensitivity Associated With Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa With RPGR Gene Variations.
    von Krusenstiern L; Liu J; Liao E; Gow JA; Chen G; Ong T; Lotery AJ; Jalil A; Lam BL; MacLaren RE;
    JAMA Ophthalmol; 2023 Mar; 141(3):275-283. PubMed ID: 36757689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dose-response relationship of subretinal gene therapy with rAAV2tYF-CB-h
    Hassan S; Hsu Y; Thompson JM; Kalmanek E; VandeLune JA; Stanley S; Drack AV
    Front Med (Lausanne); 2024; 11():1304819. PubMed ID: 38414621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.